Glutamic acid (Glutaminic acid)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceGlutamic acidGlutamic acid
Similar drugsTo uncover
  • Glutamic acid
    pills inwards 
    MARBIOFARM, OJSC     Russia
  • Glutamic acid
    pills inwards 
    TATHIMFARMPREPARATY, JSC     Russia
    • Dosage form: & nbspcoated tablets
    Composition:

    For one tablet:

    active substance: glutamic acid 0.25 g;

    auxiliary substances of the core: potato starch 0.0281 g, povidone (kollidon 30, plasdon K-29/32) 0.0084 g, talc 0.006 g, calcium stearate monohydrate 0.0024 g;

    excipients of the shell: sucrose (sugar) 0.089305 g, talc 0.003933 g, titanium dioxide (titanium dioxide) 0.002573 g, povidone (polyvinylpyrrolidone, plasdon K-17) 0.002018 g, silicon dioxide colloid (aerosil) 0.002115 g , beeswax 0.000028 g, paraffin liquid (vaseline oil) 0.000028 g.

    Description:

    Round, biconvex tablets, covered with a coat, white or white with a barely noticeable yellowish hue of color. Two layers are visible on the cross-section.

    Pharmacotherapeutic group:Nootropic remedy
    ATX: & nbsp

    N.06.B.X   Other psychostimulants and nootropic drugs

    A.16.A.A   Amino acids and their derivatives

    Pharmacodynamics:

    Glutamic acid is involved in protein synthesis (a substitute amino acid) and is a neurotransmitter of glutamine receptors.

    Pharmacokinetics:

    Preysystemic metabolism undergoes 95% of ingested glutamic acid, like other amino acids, does not accumulate, is fully included in the glutamic acid pool of the body.

    Indications:

    Replenishment of glutamic acid deficiency.

    Contraindications:

    Hypersensitivity to the components of the drug, febrile syndrome, hepatic and / or renal failure, peptic ulcer of stomach and duodenum, anemia, leukopenia; increased excitability, violent psychotic reactions; nephrotic syndrome; oppression of bone marrow hematopoiesis; obesity; deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption.

    Children under 18 years.

    Carefully:Diseases of the liver.
    Pregnancy and lactation:

    Apply on the advice of a doctor.

    The use of the drug is possible if the expected benefit exceeds the risk for the fetus and the baby.

    Dosing and Administration:

    Inside, for 15-30 minutes before meals (with the development of dyspepsia - during or after meals).

    Adults - 1 g 2-3 times a day.

    The course of treatment is from 1-2 to 6-12 months.

    Side effects:

    Allergic reactions, vomiting, diarrhea, abdominal pain, nausea, increased excitability.

    With prolonged use - anemia, leukopenia, irritation of the mucous membrane of the mouth, cracks in the lips.

    Overdose:

    In case of an overdose, dose-dependent undesirable drug reactions are amplified, since the allergic reactions described in the "Side effect" section are dose-independent.

    Interaction:

    With myopathy and muscular dystrophy glutamic acid more effective in conjunction with pahikarpinom or glycine.

    Special instructions:

    During the period of treatment, it is necessary to conduct general clinical tests of blood and urine.

    If adverse reactions occur, it is recommended to reduce the dose of glutamic acid.

    Effect on the ability to drive transp. cf. and fur:

    The intake of glutamic acid does not affect the ability to drive vehicles or other mechanisms during the period of application.

    Form release / dosage:

    The tablets covered with a cover, 250 mg.

    Packaging:

    10 tablets per contour cell packaging made of polyvinylchloride film and aluminum foil.

    For 60 tablets in a jar of polymer materials.

    Each jar or 6 contour squares, together with the instruction for use, is placed in a pack of cardboard for consumer containers.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002250
    Date of registration:26.09.2013
    Expiration Date:26.09.2018
    The owner of the registration certificate:MARBIOFARM, OJSC MARBIOFARM, OJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspMARBIOFARM, OJSCMARBIOFARM, OJSC
    Information update date: & nbsp01.05.2017
    Illustrated instructions
      Instructions
      Up